Top Glucagon like Peptide 1 (GLP 1) Agonists Companies in Latin America

  1. AstraZeneca

  2. Novo Nordisk

  3. Eli Lilly and Company

  4. Sanofi

  5. Hypera S.A.

*Disclaimer: Top companies sorted in no particular order

Latin America Glucagon-like Peptide-1 (GLP-1) Agonists Market Major Players

Latin America Glucagon-like Peptide-1 (GLP-1) Agonists - Competitive Concentration

Latin America Glucagon-like Peptide-1 (GLP-1) Agonists Market Concentration

List of Glucagon like Peptide 1 (GLP 1) Agonists Companies in Latin America

  • Amgen

  • AstraZeneca

  • Biocon

  • Biomm S.A.

  • Boehringer Ingelheim International GmBH

  • Bristol-Myers Squibb

  • Eli Lilly and Company

  • Eurofarma

  • Glenmark Pharmaceuticals

  • Hypera S.A.

  • Novartis

  • Novo Nordisk

  • Pfizer

  • Probiomed

  • Sanofi

  • Takeda Pharmaceuticals

  • Teva Pharmaceutcials Limited

  • Torrent Pharmaceuticals

Get more insights on Latin America Glucagon-like Peptide-1 (GLP-1) Agonists industry from our comprehensive report